A Comparison of Spirapril and Isradipine in Patients with Diabetic Nephropathy and Hypertension

References

• Andersen A R, Christiansen J S, Andersen J K, Kreiner S, Deckert T. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: an epidemiological study. Diabetologia 1983; 25: 496–501
   PubMed Web of Science ®Google Scholar
• Mogensen C E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685–8
   PubMed Web of Science ®Google Scholar
• Parving H-H, Andersen A R, Smidt U M, Svendsen P A. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983; ii: 1175–9
   Google Scholar
• Parving H-H, Hommel E. Prognosis in diabetic nephropathy. Br Med J 1989; 299: 230–3
   PubMed Web of Science ®Google Scholar
• Mathiesen E R, Borch-Johnsen K, Jensen D V, Deckert T. Improved survival in patients with diabetic nephropathy. Diabetologia 1989; 32: 884–6
   PubMed Web of Science ®Google Scholar
• Parving H-H, Smidt U M, Mathiesen E R, Hommel E. Ten years experiences with antihypertensive treatment in diabetic nephropathy. Diabetologia 1991; 34: 38A, (Suppl 2)
   Google Scholar
• Parving H-H, Hommel E, Nielsen M D, Giese J. Effect of captopril on blood pressure and kidney function in normotensive insulin-dependent diabetic patients with nephropathy. Br Med J 1989; 299: 533–6
   PubMed Web of Science ®Google Scholar
• Hommel E, Parving H, Mathiesen E, Edsberg B, Damkjær M, Giese J. Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J 1986; 293: 467–70
   PubMed Web of Science ®Google Scholar
• Marre M, Leblanc H, Suarez L, Guyenne T-T, Menard J, Passa P. Converting enzyme inhibition and kidney function in normotensive diabetic patients with persistent albuminuria. Br Med J 1987; 294: 1448–52
   PubMed Web of Science ®Google Scholar
• Mathiesen E R, Hommel E, Giese J, Parving H-H. Captopril postpones and may even prevent development of diabetic nephropathy. Br Med J 1991; 303: 81–7
   PubMed Web of Science ®Google Scholar
• Björck S, Mulec H, Johnsen S A, Norden G, Aurell M. Renal protective effect of enalapril in diabetic nephropathy. Br Med J 1992; 304: 339–43
   PubMed Web of Science ®Google Scholar
• Bakris G. Effects of diltiazen or lisinopril on massive proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 112: 707–8
   PubMed Web of Science ®Google Scholar
• De Marie B K, Bakris G L. Effects of different calcium antagonists on proteinuria associated with diabetes mellitus. Ann Intern Med 1990; 113: 987–8
   PubMed Web of Science ®Google Scholar
• Mimran A, Insua A, Ribstein J, Bringer J, Monnier L. Comparative effect of captopril and nifedipine in normotensive patients with incipient nephropathy. Diabetes Care 1988; 11: 850–3
   PubMed Web of Science ®Google Scholar
• Nørgaard K, Jensen T, Feldt-Rasmussen B. Effects of isradipine in insulin-dependent diabetic patients with normotension and nephropathy. J Hum Hypertens 1992; 6: 145–50
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Mathiesen E R, Deckert T, Giese J, Christensen N J, Bent-Hansen L, Nielsen M D. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin aldosterone and catecholamines in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987; 30: 610–7
   PubMed Web of Science ®Google Scholar
• Weidmann P, Beretta-Piccoli C, Keusch G. Sodium-volume factor cardio-vascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med 1979; 67: 779–84
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B. Microalbuminuria and clinical nephropathy in type 1 (insulin-dependent) diabetes mellitus: pathophysiological mechanisms and intervention studies. Danish Med Bul 1989; 36: 405–15
   PubMed Web of Science ®Google Scholar
• Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988; 31: 142–5
   PubMed Web of Science ®Google Scholar
• Jones S L, Close C F, Mattock M B, Jarrett R J, Keen H, Viberti G C. Plasma lipid and coagulation factor concentrations in insulin-dependent diabetics with albuminuria. Br Med J 1989; 298: 487–90
   PubMed Web of Science ®Google Scholar
• Borch-Johnsen K, Kreiner S. Proteinuria-a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 1987; 294: 1651–5
   PubMed Web of Science ®Google Scholar
• Evens R G, Baer L, Gill J R, Bartter F C. Exchangeable sodium determinations by an isotope balance and a whole-body counter method. J Clin Endocrinol 1968; 28: 1645–50
   Web of Science ®Google Scholar
• Parving H-H, Gyntelberg F. Transcapillary escape rate of albumin and plasma volume in essential hypertension. Circ Res 1973; 32: 643–51
   PubMed Web of Science ®Google Scholar
• Brøchner-Mortensen J. Glomerular filtration rate and extracellular fluid volumes during normoglycemia and moderate hyperglycemia in diabetics. Scand J Clin Lab Invest 1973; 32: 311–6
   PubMed Web of Science ®Google Scholar
• Ladegaard-Pedersen H J. Measurements of extracellular volume and renal clearance by a single injection of insulin. Scand J Clin Lab Invest 1972; 29: 145–53
   PubMed Web of Science ®Google Scholar
• Larsen K. Creatinine assay by a reaction-kinetic principle. Clin Chem Acta 1972; 41: 209–17
   PubMed Web of Science ®Google Scholar
• Friedwald W T, Levy R I, Frederickson D S. Estimation of the concentration of low-density cholesterol in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Ingerslev J A. Sensitive ELISA for von Willebrand factor (vWf: Ag). Scand J Clin Lab Invest 1987; 47: 143–9
   PubMed Web of Science ®Google Scholar
• Jacobsen K. Method for the determination of fibrinogen in plasma. Scand J Clin Lab Invest 1955; 14–6, Suppl 14
   Web of Science ®Google Scholar
• Feldt-Rasmussen B, Deckert M, Dinesen B. Beta2-microglobulin in urine and serum determined by a micro-ELISA technique. Scand J Clin Lab Invest 1986; 46: 791–3
   PubMed Web of Science ®Google Scholar
• Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay-an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985; 45: 539–44
   PubMed Web of Science ®Google Scholar
• Sullivan P, Kelleher M, Twomey M, Dineen M. Effects of converting enzyme inhibition on blood pressure plasma renin activity (PRA) and plasma aldosterone in hypertensive diabetics compared to patients with essential hypertension. J Hypertens 1985; 3: 359–63
   PubMed Web of Science ®Google Scholar
• Holdaas H, Hartmann A, Lien M G. Contrasting effects of lisinopril and nifedipine on albuminuria and tubular transport functions in insulin dependent diabetics with nephropathy. J Int Med 1991; 229: 163–70
   PubMed Web of Science ®Google Scholar
• Stein P P, Black H R. Drug treatment of hypertension in patients with diabetes mellitus. Diabetes Care 1991; 14: 425–48
   PubMed Web of Science ®Google Scholar
• Investigator's brochure: Clinical evaluation of spirapril
   Google Scholar
• Doyle A E. Comparison between perindopril and nifedipine in hypertensive and normotensive diabetics with microalbuminuria. Melbourne Diabetic Nephropathy Study Group. BR Med J 1991; 302: 210–15
   PubMedGoogle Scholar
• Giorato C, Fioretto P, Trevisan R. Captopril treatment normalizes baseline atrial natriuretic peptide levels and ANP response to isotonic volume expansion in hypertensive Type 1 (insulin-dependent) diabetic patients. Diabetologia 1989; 32: 492A
   Web of Science ®Google Scholar
• Krusell L R, Jespersen L T, Schmitz A, Thomsen K, Pedersen O L. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine. Hypertension 1987; 10: 577–81
   PubMed Web of Science ®Google Scholar
• Ruilope L, Miranda B, Oliet A, Alcazar J, Bigorra J, Rodicio J. Persistence of the natriuretic effect of calcium entry blockers. J Cardiovasc Pharmacol 1988; 12: 136–9, (Suppl 14)
   Web of Science ®Google Scholar
• Trust B N, Weidmann P. Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. J Hypertens 1987; 5: 81–104, (Suppl 4)
   Web of Science ®Google Scholar
• Weidmann P, Gerber A, Mordasine R. Effects of antihypertensive therapy on serum lipoproteins. Hypertension 1983; 5: 120–31, (Suppl III)
   Web of Science ®Google Scholar
• Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorthiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989; 321: 868–73
   PubMed Web of Science ®Google Scholar
• Bhathagar S K, Amin M MA, Al-yusuf A R. Diabetogenic effects of nifedipine. Br Med J 1984; 289: 19A
   Google Scholar
• Mortensen H B, Vestermmark S, Kastrup K W. Metabolic control in children with insulin dependent diabetes mellitus assessed by haemoglobin A1c. Acta Pædiatr Scand 1982; 71: 217–22
   PubMed Web of Science ®Google Scholar